Patents by Inventor David A. G. Deacon

David A. G. Deacon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11590058
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: February 28, 2023
    Assignee: Ria Technology Management Inc.
    Inventors: David A. G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20220180768
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: March 1, 2022
    Publication date: June 9, 2022
    Inventors: David A. G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20220117851
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: December 30, 2021
    Publication date: April 21, 2022
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Patent number: 11234902
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: February 1, 2022
    Assignee: DxRx, Inc.
    Inventors: David A. G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20210069066
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 11, 2021
    Applicant: DxRx, Inc.
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Patent number: 10864143
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: December 15, 2020
    Assignee: DxRx, Inc.
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20200380884
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: August 17, 2020
    Publication date: December 3, 2020
    Applicant: DxRx, Inc.
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20200206086
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: March 9, 2020
    Publication date: July 2, 2020
    Applicant: DxRx, Inc.
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Patent number: 10617606
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: April 14, 2020
    Assignee: DxRx, Inc.
    Inventors: David A. G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20180182258
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Applicant: DxRx, Inc.
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20180182497
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Applicant: DxRx, Inc.
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20180177684
    Abstract: Patients with substance abuse problems may be prescribed regular medication that dulls the positive effects of the substance. However, one of the largest challenges for substance abuse patients is that many do not regularly take their medication as they want to experience the high of the substance. Accordingly, systems and methods have been developed for medication sessions that distract the patient from taking the medicine by incorporating the reminder and other med actions in close temporal proximity.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Applicant: DxRx, Inc.
    Inventors: David A.G. Deacon, Robert P. Nix, John E. Mendelson
  • Publication number: 20090192871
    Abstract: Tools for enhancing participation in an web-based social network of businesses. For instance, such tools may encourage members of such networks to invite other members, providing viral growth of the network. As another example, the tools may encourage members of such networks to improve their web sites, which effectively will produce more traffic at such web sites. Because, in an aspect, some embodiments also include serving advertisements on web pages at members' web sites, increased traffic at such web sites results in additional “hits” on the served advertisements, producing additional revenue for the member and for the provider that maintains the business social network and/or serves the advertisements.
    Type: Application
    Filed: January 29, 2008
    Publication date: July 30, 2009
    Applicant: LinksManager LLC
    Inventors: David A.G. Deacon, Rock Clapper, Jessica Verrilli
  • Patent number: 7359608
    Abstract: A well may be formed for access to an optical waveguide core by a process that results in an L-shaped well. The L-shaped well may then be filled with a polymer. By controlling the size of each portion of well, the occurrence of bubbles within the well and cuts to the core may be reduced.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: April 15, 2008
    Assignee: Intel Corporation
    Inventors: Ut Tran, David A. G. Deacon, Shing Man Lee
  • Patent number: 7317852
    Abstract: A set of three gratings may be operated in a vernier loop fashion to select a particular wavelength from a wavelength division multiplexed system. As a result, an optical add/drop multiplexer may be provided that can be tuned to select a desired wavelength. In one embodiment, the tuning may be done thermo-optically.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: January 8, 2008
    Assignee: Intel Corporation
    Inventors: David A. G. Deacon, Steven J. Madden, Jorg Hubner
  • Patent number: 7146086
    Abstract: A well may be formed for access to an optical waveguide core by a process that results in an L-shaped well. The L-shaped well may then be filled with a polymer. By controlling the size of each portion of well, the occurrence of bubbles within the well and cuts to the core may be reduced.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: December 5, 2006
    Assignee: Intel Corporation
    Inventors: Ut Tran, David A. G. Deacon, Shing Man Lee
  • Patent number: 7110622
    Abstract: A set of three gratings may be operated in a vernier loop fashion to select a particular wavelength from a wavelength division multiplexed system. As a result, an optical add/drop multiplexer may be provided that can be tuned to select a desired wavelength. In one embodiment, the tuning may be done thermo-optically.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: September 19, 2006
    Assignee: Intel Corporation
    Inventors: David A. G. Deacon, Steven J. Madden, Jorg Hubner
  • Patent number: 7023886
    Abstract: Embodiments of a wavelength tunable optical coupler, integrated optical components, and lasers are disclosed. The tunable optical coupler, the integrated optical components, and the lasers include thermo-optic organic material that has an index of refraction which can quickly vary in response to changes in temperature. By controlling the temperature in the thermo-optic organic material through the use of heaters or coolers, the optical coupler, the integrated optical components, and the lasers can be quickly and selectively tuned over a broad range of wavelengths with high spectral selectivity.
    Type: Grant
    Filed: November 8, 2001
    Date of Patent: April 4, 2006
    Assignee: Intel Corporation
    Inventor: David A. G. Deacon
  • Patent number: 6934313
    Abstract: A method of making permanent adjustments to the resonant cavity of a laser device in order to match its free spectral range to a specified frequency interval involves monitoring the optical output produced during laser operation or cavity illumination with diagnostic light, determining the free spectral range from the monitored output, and then permanently modifying the effective refractive index of an intracavity waveguide segment of the laser device according to the determined free spectral range obtained from the monitoring step until the desired match is achieved. The permanent index changes can be done in several ways, including illumination of the intracavity segment with an energetic beam (e.g. UV light) to induce a chemical alteration in the waveguide material, such as polymer cross-linking in the waveguide cladding. Evaporative deposition or ablative removal of intracavity waveguide material would also produce the desired permanent modifications.
    Type: Grant
    Filed: November 4, 1999
    Date of Patent: August 23, 2005
    Assignee: Intel Corporation
    Inventor: David A. G. Deacon
  • Patent number: 6928208
    Abstract: A set of three gratings may be operated in a vernier loop fashion to select a particular wavelength from a wavelength division multiplexed system. As a result, an optical add/drop multiplexer may be provided that can be tuned to select a desired wavelength. In one embodiment, the tuning may be done thermo-optically.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: August 9, 2005
    Assignee: Intel Corporation
    Inventors: David A.G. Deacon, Steven J. Madden, Jorg Hubner